 | • レポートコード：MRC2Q12-18845 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、抗ヒスタミン剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 抗ヒスタミン剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗ヒスタミン剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗ヒスタミン剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの抗ヒスタミン剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の抗ヒスタミン剤の売上および2028年までの予測に焦点を当てています。 抗ヒスタミン剤のグローバル主要企業には、Merck、Viatris、Organon、Sun Pharmaceutical Industries、Cardinal Health、Fresenius Kabi、Hikma Pharmaceutical、Meda Pharmaceuticals、Armas Pharmaceuticals、Strides Pharma、Aurobindo Pharma、Perrigo Pharmaceuticals、Micro Labs USA、Sciegen Pharmaceutical、Zydus Pharmaceuticals、Alcon Laboratories、Breckenridge Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗ヒスタミン剤市場は、タイプとアプリケーションによって区分されます。世界の抗ヒスタミン剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 10mg、20mg、30mg、その他 【アプリケーション別セグメント】 病院、診療所、薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗ヒスタミン剤製品概要 - タイプ別市場（10mg、20mg、30mg、その他） - アプリケーション別市場（病院、診療所、薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の抗ヒスタミン剤販売量予測2017-2028 - 世界の抗ヒスタミン剤売上予測2017-2028 - 抗ヒスタミン剤の地域別販売量 - 抗ヒスタミン剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗ヒスタミン剤販売量 - 主要メーカー別抗ヒスタミン剤売上 - 主要メーカー別抗ヒスタミン剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（10mg、20mg、30mg、その他） - 抗ヒスタミン剤のタイプ別販売量 - 抗ヒスタミン剤のタイプ別売上 - 抗ヒスタミン剤のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、薬局、その他） - 抗ヒスタミン剤のアプリケーション別販売量 - 抗ヒスタミン剤のアプリケーション別売上 - 抗ヒスタミン剤のアプリケーション別価格 ・北米市場 - 北米の抗ヒスタミン剤市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒスタミン剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗ヒスタミン剤市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒスタミン剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗ヒスタミン剤市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒスタミン剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗ヒスタミン剤市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒスタミン剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗ヒスタミン剤市場規模（タイプ別、アプリケーション別） - 主要国別の抗ヒスタミン剤市場規模（トルコ、サウジアラビア） ・企業情報 Merck、Viatris、Organon、Sun Pharmaceutical Industries、Cardinal Health、Fresenius Kabi、Hikma Pharmaceutical、Meda Pharmaceuticals、Armas Pharmaceuticals、Strides Pharma、Aurobindo Pharma、Perrigo Pharmaceuticals、Micro Labs USA、Sciegen Pharmaceutical、Zydus Pharmaceuticals、Alcon Laboratories、Breckenridge Pharmaceutical ・産業チェーン及び販売チャネル分析 - 抗ヒスタミン剤の産業チェーン分析 - 抗ヒスタミン剤の原材料 - 抗ヒスタミン剤の生産プロセス - 抗ヒスタミン剤の販売及びマーケティング - 抗ヒスタミン剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗ヒスタミン剤の産業動向 - 抗ヒスタミン剤のマーケットドライバー - 抗ヒスタミン剤の課題 - 抗ヒスタミン剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Antihistamines estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Antihistamines is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Antihistamines is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Antihistamines is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Antihistamines include Merck, Viatris, Organon, Sun Pharmaceutical Industries, Cardinal Health, Fresenius Kabi, Hikma Pharmaceutical, Meda Pharmaceuticals and Armas Pharmaceuticals, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antihistamines companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Antihistamines market. Further, it explains the major drivers and regional dynamics of the global Antihistamines market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Merck
Viatris
Organon
Sun Pharmaceutical Industries
Cardinal Health
Fresenius Kabi
Hikma Pharmaceutical
Meda Pharmaceuticals
Armas Pharmaceuticals
Strides Pharma
Aurobindo Pharma
Perrigo Pharmaceuticals
Micro Labs USA
Sciegen Pharmaceutical
Zydus Pharmaceuticals
Alcon Laboratories
Breckenridge Pharmaceutical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Antihistamines Segment by Type
10 mg
20 mg
30 mg
Others
Antihistamines Segment by Application
Hospital
Clinics
Pharmacy
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antihistamines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Antihistamines market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Antihistamines, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antihistamines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antihistamines revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Antihistamines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Antihistamines revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Viatris, Organon, Sun Pharmaceutical Industries, Cardinal Health, Fresenius Kabi, Hikma Pharmaceutical, Meda Pharmaceuticals and Armas Pharmaceuticals, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Antihistamines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antihistamines companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antihistamines revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihistamines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10 mg
1.2.3 20 mg
1.2.4 30 mg
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antihistamines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antihistamines Market Perspective (2017-2028)
2.2 Antihistamines Growth Trends by Region
2.2.1 Antihistamines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antihistamines Historic Market Size by Region (2017-2022)
2.2.3 Antihistamines Forecasted Market Size by Region (2023-2028)
2.3 Antihistamines Market Dynamics
2.3.1 Antihistamines Industry Trends
2.3.2 Antihistamines Market Drivers
2.3.3 Antihistamines Market Challenges
2.3.4 Antihistamines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antihistamines Players by Revenue
3.1.1 Global Top Antihistamines Players by Revenue (2017-2022)
3.1.2 Global Antihistamines Revenue Market Share by Players (2017-2022)
3.2 Global Antihistamines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antihistamines Revenue
3.4 Global Antihistamines Market Concentration Ratio
3.4.1 Global Antihistamines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihistamines Revenue in 2021
3.5 Antihistamines Key Players Head office and Area Served
3.6 Key Players Antihistamines Product Solution and Service
3.7 Date of Enter into Antihistamines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antihistamines Breakdown Data by Type
4.1 Global Antihistamines Historic Market Size by Type (2017-2022)
4.2 Global Antihistamines Forecasted Market Size by Type (2023-2028)
5 Antihistamines Breakdown Data by Application
5.1 Global Antihistamines Historic Market Size by Application (2017-2022)
5.2 Global Antihistamines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antihistamines Market Size (2017-2028)
6.2 North America Antihistamines Market Size by Type
6.2.1 North America Antihistamines Market Size by Type (2017-2022)
6.2.2 North America Antihistamines Market Size by Type (2023-2028)
6.2.3 North America Antihistamines Market Share by Type (2017-2028)
6.3 North America Antihistamines Market Size by Application
6.3.1 North America Antihistamines Market Size by Application (2017-2022)
6.3.2 North America Antihistamines Market Size by Application (2023-2028)
6.3.3 North America Antihistamines Market Share by Application (2017-2028)
6.4 North America Antihistamines Market Size by Country
6.4.1 North America Antihistamines Market Size by Country (2017-2022)
6.4.2 North America Antihistamines Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Antihistamines Market Size (2017-2028)
7.2 Europe Antihistamines Market Size by Type
7.2.1 Europe Antihistamines Market Size by Type (2017-2022)
7.2.2 Europe Antihistamines Market Size by Type (2023-2028)
7.2.3 Europe Antihistamines Market Share by Type (2017-2028)
7.3 Europe Antihistamines Market Size by Application
7.3.1 Europe Antihistamines Market Size by Application (2017-2022)
7.3.2 Europe Antihistamines Market Size by Application (2023-2028)
7.3.3 Europe Antihistamines Market Share by Application (2017-2028)
7.4 Europe Antihistamines Market Size by Country
7.4.1 Europe Antihistamines Market Size by Country (2017-2022)
7.4.2 Europe Antihistamines Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antihistamines Market Size (2017-2028)
8.2 Asia-Pacific Antihistamines Market Size by Type
8.2.1 Asia-Pacific Antihistamines Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antihistamines Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antihistamines Market Share by Type (2017-2028)
8.3 Asia-Pacific Antihistamines Market Size by Application
8.3.1 Asia-Pacific Antihistamines Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antihistamines Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antihistamines Market Share by Application (2017-2028)
8.4 Asia-Pacific Antihistamines Market Size by Region
8.4.1 Asia-Pacific Antihistamines Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antihistamines Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antihistamines Market Size (2017-2028)
9.2 Latin America Antihistamines Market Size by Type
9.2.1 Latin America Antihistamines Market Size by Type (2017-2022)
9.2.2 Latin America Antihistamines Market Size by Type (2023-2028)
9.2.3 Latin America Antihistamines Market Share by Type (2017-2028)
9.3 Latin America Antihistamines Market Size by Application
9.3.1 Latin America Antihistamines Market Size by Application (2017-2022)
9.3.2 Latin America Antihistamines Market Size by Application (2023-2028)
9.3.3 Latin America Antihistamines Market Share by Application (2017-2028)
9.4 Latin America Antihistamines Market Size by Country
9.4.1 Latin America Antihistamines Market Size by Country (2017-2022)
9.4.2 Latin America Antihistamines Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antihistamines Market Size (2017-2028)
10.2 Middle East & Africa Antihistamines Market Size by Type
10.2.1 Middle East & Africa Antihistamines Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antihistamines Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antihistamines Market Share by Type (2017-2028)
10.3 Middle East & Africa Antihistamines Market Size by Application
10.3.1 Middle East & Africa Antihistamines Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antihistamines Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antihistamines Market Share by Application (2017-2028)
10.4 Middle East & Africa Antihistamines Market Size by Country
10.4.1 Middle East & Africa Antihistamines Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antihistamines Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Antihistamines Introduction
11.1.4 Merck Revenue in Antihistamines Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Viatris
11.2.1 Viatris Company Details
11.2.2 Viatris Business Overview
11.2.3 Viatris Antihistamines Introduction
11.2.4 Viatris Revenue in Antihistamines Business (2017-2022)
11.2.5 Viatris Recent Developments
11.3 Organon
11.3.1 Organon Company Details
11.3.2 Organon Business Overview
11.3.3 Organon Antihistamines Introduction
11.3.4 Organon Revenue in Antihistamines Business (2017-2022)
11.3.5 Organon Recent Developments
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Details
11.4.2 Sun Pharmaceutical Industries Business Overview
11.4.3 Sun Pharmaceutical Industries Antihistamines Introduction
11.4.4 Sun Pharmaceutical Industries Revenue in Antihistamines Business (2017-2022)
11.4.5 Sun Pharmaceutical Industries Recent Developments
11.5 Cardinal Health
11.5.1 Cardinal Health Company Details
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Antihistamines Introduction
11.5.4 Cardinal Health Revenue in Antihistamines Business (2017-2022)
11.5.5 Cardinal Health Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Antihistamines Introduction
11.6.4 Fresenius Kabi Revenue in Antihistamines Business (2017-2022)
11.6.5 Fresenius Kabi Recent Developments
11.7 Hikma Pharmaceutical
11.7.1 Hikma Pharmaceutical Company Details
11.7.2 Hikma Pharmaceutical Business Overview
11.7.3 Hikma Pharmaceutical Antihistamines Introduction
11.7.4 Hikma Pharmaceutical Revenue in Antihistamines Business (2017-2022)
11.7.5 Hikma Pharmaceutical Recent Developments
11.8 Meda Pharmaceuticals
11.8.1 Meda Pharmaceuticals Company Details
11.8.2 Meda Pharmaceuticals Business Overview
11.8.3 Meda Pharmaceuticals Antihistamines Introduction
11.8.4 Meda Pharmaceuticals Revenue in Antihistamines Business (2017-2022)
11.8.5 Meda Pharmaceuticals Recent Developments
11.9 Armas Pharmaceuticals
11.9.1 Armas Pharmaceuticals Company Details
11.9.2 Armas Pharmaceuticals Business Overview
11.9.3 Armas Pharmaceuticals Antihistamines Introduction
11.9.4 Armas Pharmaceuticals Revenue in Antihistamines Business (2017-2022)
11.9.5 Armas Pharmaceuticals Recent Developments
11.10 Strides Pharma
11.10.1 Strides Pharma Company Details
11.10.2 Strides Pharma Business Overview
11.10.3 Strides Pharma Antihistamines Introduction
11.10.4 Strides Pharma Revenue in Antihistamines Business (2017-2022)
11.10.5 Strides Pharma Recent Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Details
11.11.2 Aurobindo Pharma Business Overview
11.11.3 Aurobindo Pharma Antihistamines Introduction
11.11.4 Aurobindo Pharma Revenue in Antihistamines Business (2017-2022)
11.11.5 Aurobindo Pharma Recent Developments
11.12 Perrigo Pharmaceuticals
11.12.1 Perrigo Pharmaceuticals Company Details
11.12.2 Perrigo Pharmaceuticals Business Overview
11.12.3 Perrigo Pharmaceuticals Antihistamines Introduction
11.12.4 Perrigo Pharmaceuticals Revenue in Antihistamines Business (2017-2022)
11.12.5 Perrigo Pharmaceuticals Recent Developments
11.13 Micro Labs USA
11.13.1 Micro Labs USA Company Details
11.13.2 Micro Labs USA Business Overview
11.13.3 Micro Labs USA Antihistamines Introduction
11.13.4 Micro Labs USA Revenue in Antihistamines Business (2017-2022)
11.13.5 Micro Labs USA Recent Developments
11.14 Sciegen Pharmaceutical
11.14.1 Sciegen Pharmaceutical Company Details
11.14.2 Sciegen Pharmaceutical Business Overview
11.14.3 Sciegen Pharmaceutical Antihistamines Introduction
11.14.4 Sciegen Pharmaceutical Revenue in Antihistamines Business (2017-2022)
11.14.5 Sciegen Pharmaceutical Recent Developments
11.15 Zydus Pharmaceuticals
11.15.1 Zydus Pharmaceuticals Company Details
11.15.2 Zydus Pharmaceuticals Business Overview
11.15.3 Zydus Pharmaceuticals Antihistamines Introduction
11.15.4 Zydus Pharmaceuticals Revenue in Antihistamines Business (2017-2022)
11.15.5 Zydus Pharmaceuticals Recent Developments
11.16 Alcon Laboratories
11.16.1 Alcon Laboratories Company Details
11.16.2 Alcon Laboratories Business Overview
11.16.3 Alcon Laboratories Antihistamines Introduction
11.16.4 Alcon Laboratories Revenue in Antihistamines Business (2017-2022)
11.16.5 Alcon Laboratories Recent Developments
11.17 Breckenridge Pharmaceutical
11.17.1 Breckenridge Pharmaceutical Company Details
11.17.2 Breckenridge Pharmaceutical Business Overview
11.17.3 Breckenridge Pharmaceutical Antihistamines Introduction
11.17.4 Breckenridge Pharmaceutical Revenue in Antihistamines Business (2017-2022)
11.17.5 Breckenridge Pharmaceutical Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer